Cash Equivalents - Talkmed Group Ltd (SGX:5G3) - Alpha Spread
T

Talkmed Group Ltd
SGX:5G3

Watchlist Manager
Talkmed Group Ltd
SGX:5G3
Watchlist
Price: 0.415 SGD 3.75% Market Closed
Market Cap: 550.6m SGD
Have any thoughts about
Talkmed Group Ltd?
Write Note

Talkmed Group Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Talkmed Group Ltd
Cash Equivalents Peer Comparison

Comparables:
P8A
QC7
5NG
1B1
EUDA

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
T
Talkmed Group Ltd
SGX:5G3
Cash Equivalents
S$85.7m
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Cordlife Group Ltd
SGX:P8A
Cash Equivalents
S$17.4m
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
-6%
Q & M Dental Group (Singapore) Ltd
SGX:QC7
Cash Equivalents
S$34m
CAGR 3-Years
-11%
CAGR 5-Years
6%
CAGR 10-Years
2%
Healthway Medical Corporation Ltd
SGX:5NG
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
HC Surgical Specialists Ltd
SGX:1B1
Cash Equivalents
S$7.4m
CAGR 3-Years
-12%
CAGR 5-Years
8%
CAGR 10-Years
N/A
EUDA Health Holdings Ltd
NASDAQ:EUDA
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Talkmed Group Ltd's Cash Equivalents?
Cash Equivalents
85.7m SGD

Based on the financial report for Jun 30, 2024, Talkmed Group Ltd's Cash Equivalents amounts to 85.7m SGD.

What is Talkmed Group Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
3%

Over the last year, the Cash Equivalents growth was 6%. The average annual Cash Equivalents growth rates for Talkmed Group Ltd have been 2% over the past three years , 3% over the past five years .

Back to Top